APA

Kavian N., Servettaz A., Mongaret C., Wang A., Nicco C., Chéreau C., Grange P., Vuiblet V., Birembaut P., Diebold M., Weill B., Dupin N. & Batteux F. (20101130). Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model. : Arthritis and rheumatism.

Chicago

Kavian Niloufar, Servettaz Amélie, Mongaret Céline, Wang Andrew, Nicco Carole, Chéreau Christiane, Grange Philippe, Vuiblet Vincent, Birembaut Philippe, Diebold Marie-Danièle, Weill Bernard, Dupin Nicolas and Batteux Frédéric. 20101130. Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model. : Arthritis and rheumatism.

Harvard

Kavian N., Servettaz A., Mongaret C., Wang A., Nicco C., Chéreau C., Grange P., Vuiblet V., Birembaut P., Diebold M., Weill B., Dupin N. and Batteux F. (20101130). Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model. : Arthritis and rheumatism.

MLA

Kavian Niloufar, Servettaz Amélie, Mongaret Céline, Wang Andrew, Nicco Carole, Chéreau Christiane, Grange Philippe, Vuiblet Vincent, Birembaut Philippe, Diebold Marie-Danièle, Weill Bernard, Dupin Nicolas and Batteux Frédéric. Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model. : Arthritis and rheumatism. 20101130.